Glox Therapeutics
About:
Glox Therapeutics creates precision antibiotics through the use of engineered protein bacteriocins.
Website: https://gloxtherapeutics.com/
Top Investors: PACE-AMR, Scottish Enterprise, Boehringer Ingelheim Venture Fund
Description:
Glox Therapeutics is a company that is pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins.
Total Funding Amount:
5.3M GBP
Headquarters Location:
Glasgow, Glasgow City, United Kingdom
Founded Date:
2023-01-01
Contact Email:
j.clark(AT)gloxtherapeutics.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-11-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai